Open access
Open access
Powered by Google Translator Translator

Heart Failure/Transplantation

M-A | Mortality and clinical predictors after percutaneous mitral valve repair for secondary mitral regurgitation.

26 Jul, 2022 | 11:49h | UTC

Mortality and Clinical Predictors After Percutaneous Mitral Valve Repair for Secondary Mitral Regurgitation: A Systematic Review and Meta-Regression Analysis – Frontiers in Cardiovascular Medicine

 


Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study.

22 Jul, 2022 | 11:18h | UTC

Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study – The BMJ

 

Commentary from the author on Twitter

Under a http://creativecommons.org/licenses/by/4.0/ license

 


Review | Temporary mechanical circulatory support: devices, outcomes, and future directions.

14 Jul, 2022 | 12:23h | UTC

Temporary mechanical circulatory support: Devices, outcomes, and future directions – The Journal of Heart and Lung Transplantation

 


RCT | Myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy.

13 Jul, 2022 | 11:52h | UTC

Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy – Journal of the American College of Cardiology

Related: #ACC22 [Not published yet] – RCT: Mavacamten reduces the need for surgical intervention in patients with obstructive hypertrophic cardiomyopathy.

 


AHA Science Advisory | Elucidating the clinical implications and pathophysiology of pulmonary hypertension in heart failure with preserved ejection fraction: a call to action.

13 Jul, 2022 | 11:40h | UTC

Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association – Circulation

 


M-A | Oral iron supplementation in patients with heart failure.

13 Jul, 2022 | 11:17h | UTC

Oral iron supplementation in patients with heart failure: a systematic review and meta-analysis – ESC Heart Failure

 


AHA Scientific Statement | Escalating and de-escalating temporary mechanical circulatory support in cardiogenic shock.

8 Jul, 2022 | 12:05h | UTC

Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association – Circulation

Top Things to Know: Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock– American Heart Association

Commentary: Guiding Cardiogenic Shock Management: Filling in the (Wide) Data Gaps – American Heart Association

 


Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy.

8 Jul, 2022 | 11:53h | UTC

Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia – Clinical Cardiology

Related:

Characteristics and natural history of early-stage cardiac transthyretin amyloidosis – European Heart Journal

Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis – 2021 – Arquivos Brasileiros de Cardiologia

AHA Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis.

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases – European Heart Journal

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association – Circulation

Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis – Canadian Journal of Cardiology

AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management – JACC: CardioOncology

Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis – Circulation: Heart Failure

 


Case Series | Myocardial injury in patients with acute and subacute Chagas Disease in the Brazilian Amazon using cardiovascular magnetic resonance.

5 Jul, 2022 | 11:47h | UTC

Myocardial Injury in Patients With Acute and Subacute Chagas Disease in the Brazilian Amazon Using Cardiovascular Magnetic Resonance – Journal of the American Heart Association


Trends in advanced heart failure therapy: update on cardiac transplantation.

4 Jul, 2022 | 12:07h | UTC

Cover Story | Trends in Advanced Heart Failure Therapy: Update on Cardiac Transplantation – American College of Cardiology


Cohort Study: B‐Type Natriuretic Peptide and long‐term cardiovascular mortality in patients with coronary heart disease.

1 Jul, 2022 | 11:04h | UTC

B‐Type Natriuretic Peptide and Long‐Term Cardiovascular Mortality in Patients With Coronary Heart Disease – Journal of the American Heart Association

 


RCT: Effects of early Empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure.

30 Jun, 2022 | 11:24h | UTC

Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF) – Circulation

 


Secondary analysis of a RCT: Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes.

30 Jun, 2022 | 10:58h | UTC

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes – Circulation

Original Study: Empagliflozin in Heart Failure with a Preserved Ejection Fraction – New England Journal of Medicine

 


M-A: Comparison of mortality and hospital readmissions among patients receiving virtual ward transitional care vs. usual postdischarge care.

29 Jun, 2022 | 12:06h | UTC

Comparison of Mortality and Hospital Readmissions Among Patients Receiving Virtual Ward Transitional Care vs Usual Postdischarge Care: A Systematic Review and Meta-analysis – JAMA Network Open

 

Commentary on Twitter

 


Retrospective Cohort Study: Atrial fibrillation after surgery is linked to an increased risk of hospitalization for heart failure.

29 Jun, 2022 | 10:52h | UTC

News Release: Atrial fibrillation after surgery is linked to an increased risk of hospitalization for heart failure – European Society of Cardiology

Original Study: Post-operative atrial fibrillation and risk of heart failure hospitalization – European Heart Journal

Editorial: Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery – European Heart Journal

 

Commentary on Twitter

 


Brief Review | Never above suspicion: getting to the bottom of cardiac sarcoidosis diagnosis and treatment.

29 Jun, 2022 | 10:50h | UTC

Never Above Suspicion: Getting to the Bottom of Cardiac Sarcoidosis Diagnosis and Treatment – American College of Cardiology

 


Review: Arrhythmias and heart failure in pregnancy.

29 Jun, 2022 | 10:48h | UTC

Arrhythmias and Heart Failure in Pregnancy: A Dialogue on Multidisciplinary Collaboration – Journal of Cardiovascular Development and Disease

 


Epidemiology of myocarditis and pericarditis following mRNA vaccination by vaccine product, schedule, and interdose interval among adolescents and adults in Ontario, Canada.

27 Jun, 2022 | 11:51h | UTC

Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada – JAMA Network Open

Commentary: Young Men’s Myocarditis Risk 5 Times Higher With Moderna vs Pfizer Vax — But Canadian study finds that 8-week interval before second dose attenuates some of the risk – MedPage Today (free registration required)

 


Cohort Study: Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA.

22 Jun, 2022 | 12:07h | UTC

Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases – The Lancet

Commentaries:

COVID-19 mRNA vaccination and myocarditis or pericarditis – The Lancet

Myocarditis and Pericarditis After the COVID-19 mRNA Vaccination – American College of Cardiology

Related:

SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents – JAMA Cardiology

Myocarditis and pericarditis after COVID-19 vaccination: clinical management guidance for healthcare professionals – UK Health Security Agency

Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.

Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.

[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.

Myocarditis after BNT162b2 vaccination in Israeli adolescents.

Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

 


Cohort Study: Association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease.

22 Jun, 2022 | 11:18h | UTC

The association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease in the UK Biobank – European Journal of Preventive Cardiology

 


Cardiac xenotransplantation: challenges, evolution, and advances.

20 Jun, 2022 | 00:58h | UTC

Cardiac Xenotransplantation: Challenges, Evolution, and Advances – JACC: Basic to Translational Science

News Release: New review paper proposes framework for advancing application of animal-to-human transplantation – American College of Cardiology

Commentary: Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off – TCTMD

Related:

In 1st, US surgeons transplant pig heart into human patient – Associated Press

Results of Two Cases of Pig-to-Human Kidney Xenotransplantation – New England Journal of Medicine (link to abstract – $ for full-text)

Moving xenotransplantation research into human trials will require adjusting our expectations, researchers say – STAT

After a flurry of firsts, xenotransplantation is suddenly back in the spotlight – STAT

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.